Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'antipsychotic drug' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 146 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rijcken, CAW; Dekens-Konter, JAM; Knegtering, H; de Jong-van den Berg, LTW
      Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?

      PHARMACY WORLD & SCIENCE
    2. Theodoropoulou, S; Spanakos, G; Baxevanis, CN; Economou, M; Gritzapis, AD; Papamichail, MP; Stefanis, CN
      Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    3. Meltzer, H; Lee, MA; Jayathilake, K
      The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    4. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    5. Vinod, KY; Subhash, MN; Srinivas, BN
      Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) inactivation in regions of rat brain

      NEUROCHEMICAL RESEARCH
    6. Kim, YB; Jang, J; Chung, YM; Baeg, EH; Kim, HT; Mook-Jung, I; Kim, SU; Jung, MW; Chung, YK
      Haloperidol and clozapine increase neural activity in the rat prefrontal cortex

      NEUROSCIENCE LETTERS
    7. Niizato, K; Genda, K; Nakamura, R; Iritani, S; Ikeda, K
      Cognitive decline in schizophrenics with Alzheimer's disease: A mini-review of neuropsychological and neuropathological studies

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    8. Scheepers, FE; de Wied, CCG; Kahn, RS
      The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    9. McCartan, D; Bell, R; Green, JF; Campbell, C; Trimble, K; Pickering, A; King, DJ
      The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    10. Butterfield, MI; Becker, ME; Connor, KM; Sutherland, S; Churchill, LE; Davidson, JRT
      Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    11. Tallerico, T; Novak, G; Liu, ISC; Ulpian, C; Seeman, P
      Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex

      MOLECULAR BRAIN RESEARCH
    12. Sugiyama, A; Satoh, Y; Hashimoto, K
      In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    13. Warawa, EJ; Migler, BM; Ohnmacht, CJ; Needles, AL; Gatos, GC; McLaren, FM; Nelson, CL; Kirkland, KM
      Behavioral approach to nondyskinetic dopamine antagonists: Identification of seroquel

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Alcock, SJ; Hemsley, KM; Crocker, AD
      Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Westerink, BHC; Kawahara, Y; De Boer, P; Geels, C; De Vries, JB; Wikstrom, HV; Van Kalkeren, A; Van Vliet, B; Kruse, CG; Long, SK
      Antipsychotic drugs classified by their effects on the release of dopamineand noradrenaline in the prefrontal cortex and striatum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Barnas, C; Quiner, S; Tauscher, J; Hilger, E; Willeit, M; Kufferle, B; Asenbaum, S; Brucke, T; Rao, ML; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine 2 receptor occupancyin schizophrenic patients

      PSYCHOPHARMACOLOGY
    17. Hietala, J; Kuoppamaki, M; Majasuo, H; Palvimaki, EP; Laakso, A; Syvalahti, E
      Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist butnot antagonist binding to 5-HT2c receptors after chronic treatment

      PSYCHOPHARMACOLOGY
    18. Heidbreder, CA; Foxton, R; Cilia, J; Hughes, ZA; Shah, AJ; Atkins, A; Hunter, AJ; Hagan, JJ; Jones, DNC
      Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

      PSYCHOPHARMACOLOGY
    19. Kumari, V; Zachariah, E; Galea, A; Mehrotra, R; Taylor, D; Sharma, T
      Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers

      PSYCHOPHARMACOLOGY
    20. Hertel, P; Lindblom, N; Nomikos, GG; Svensson, TH
      Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone

      PSYCHOPHARMACOLOGY
    21. Kamel, A; Prakash, C; Saverino, C; Obach, B; Fouda, H
      Narrow-bore high-performance liquid chromatography in combination with ionspray tandem mass spectrometry for the determination of the substance P receptor antagonist ezlopitant and its two active metabolites in plasma

      JOURNAL OF CHROMATOGRAPHY B
    22. Michaud, JC; Gueudet, C; Soubrie, P
      Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons

      NEUROREPORT
    23. Meshul, CK; Allen, C
      Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion

      SYNAPSE
    24. Davidoff, SA; Chu, HM; Benes, FM
      Acute administration of SCH23390 increases D-1 receptors on nonpyramidal neurons in rat mPFC

      SYNAPSE
    25. Kusumi, I; Takahashi, Y; Suzuki, K; Kameda, K; Koyama, T
      Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D-2 and serotonin 5-HT2A receptors in the rat brain

      JOURNAL OF NEURAL TRANSMISSION
    26. Goldstein, DJ; Corbin, LA; Fung, MC
      Olanzapine-exposed pregnancies and lactation: Early experience

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    27. Berardi, D; Giannelli, A; Barnes, TRE
      Clinical correlates of akathisia in acute psychiatric inpatients

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    28. Schuld, A; Kuhn, M; Haack, M; Kraus, T; Hinze-Selch, D; Lechner, C; Pollmacher, T
      A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia

      PHARMACOPSYCHIATRY
    29. Novak, G; Seeman, P; Tallerico, T
      Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase II beta in frontal cortex

      MOLECULAR BRAIN RESEARCH
    30. Hirose, S; Ashby, CR
      Intravenous biperiden in akathisia: An open pilot study

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
    31. Copolov, DL; Link, CGG; Kowalcyk, B
      A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia

      PSYCHOLOGICAL MEDICINE
    32. Cartmell, J; Perry, KW; Salhoff, CR; Monn, JA; Schoepp, DD
      The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat

      JOURNAL OF NEUROCHEMISTRY
    33. Helmeste, DM; Tang, SW
      Dopamine D-4 receptors

      JAPANESE JOURNAL OF PHARMACOLOGY
    34. Sebens, JB; Kuipers, SD; Koch, T; Ter Horst, GJ; Korf, J
      Limited participation of 5-HT1A and 5-HT2A/2C receptors in the clozapine-induced Fos-protein expression in rat forebrain regions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    35. Nasif, FJ; Cuadra, GR; Ramirez, OA
      Effects of chronic risperidone on central noradrenergic transmission

      EUROPEAN JOURNAL OF PHARMACOLOGY
    36. Kobayashi, T; Ikeda, K; Kumanishi, T
      Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K+ (GIRK) channels expressed in Xenopus oocytes

      BRITISH JOURNAL OF PHARMACOLOGY
    37. Ichikawa, J; Meltzer, HY
      The effect of serotonin(1A) receptor agonism on antipsychotic drug-induceddopamine release in rat striatum and nucleus accumbens

      BRAIN RESEARCH
    38. Bigliani, V; Mulligan, RS; Acton, PD; Ohlsen, RI; Pike, VW; Ell, PJ; Gacinovic, S; Kerwin, RW; Pilowsky, LS
      Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study

      PSYCHOPHARMACOLOGY
    39. Mihara, K; Kondo, T; Suzuki, A; Yasui, N; Nagashima, U; Ono, S; Otani, K; Kaneko, S
      Prolactin response to nemonapride, a selective antagonist for D-2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene

      PSYCHOPHARMACOLOGY
    40. Yoshimura, R; Yanagihara, N; Hara, K; Terao, T; Nakamura, J; Ueno, S; Toyohira, Y; Uezono, Y; Kaneko, S; Kawamura, M; Abe, K; Izumi, F
      Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells

      PSYCHOPHARMACOLOGY
    41. Koshino, Y
      Algorithm for treatment-refractory schizophrenia

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    42. Guttman, R; Altman, RD; Karlan, MS
      Report of the Council on Scientific Affairs - Use of restraints for patients in nursing homes

      ARCHIVES OF FAMILY MEDICINE
    43. Hughes, CM; Lapane, KL; Mor, V
      Impact of legislation on nursing home care in the United States: lessons for the United Kingdom

      BRITISH MEDICAL JOURNAL
    44. Grassi, B; Ferrari, R; Epifani, M; Dragoni, C; Cohen, S; Scarone, S
      Clozapine lacks previous clinical efficacy when restarted after a period of discontinuation: A case series

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    45. Jones, EA; McMillen, BA
      The cardiovascular effects of amperozide: Interactions with cocaine

      PHARMACOLOGY & TOXICOLOGY
    46. Levant, B; Garimelli, B; Shafer, RA; Merchant, KM
      Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride

      NEUROPSYCHOPHARMACOLOGY
    47. Minabe, Y; Matsuno, K; Ashby, CR
      Acute and chronic administration of the selective sigma(1) receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study

      SYNAPSE
    48. Molho, ES; Factor, SA
      Worsening of motor features of Parkinsonism with olanzapine

      MOVEMENT DISORDERS
    49. Ninan, I; Kulkarni, SK
      Antagonism by pimozide of olanzapine-induced hypothermia

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    50. Patat, A; Rosenzweig, P; Miget, N; Allain, H; Gandon, JM
      Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions inhealthy sleep-deprived subjects

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    51. Zheng, P; Zhang, XX; Bunney, BS; Shi, WX
      Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine

      NEUROSCIENCE
    52. Okuno, S; Hamada, H; Fujiki, Y; Yasuoka, M; Watanabe, H; Yamada, N; Sohda, S; Kubo, T
      Transplacental exposure to antipsychotic drugs during pregnancy and megacystis in the fetus

      PRENATAL DIAGNOSIS
    53. Chen, ACH; Gurling, HMD
      D-2 dopamine receptor but not AMPA and kainate glutamate receptor genes show altered expression in response to long term treatment with trans- and cis-flupenthixol in the rat brain

      MOLECULAR BRAIN RESEARCH
    54. Rademacher, DJ; Kuppinger, HE; Thompson, KJ; Harrington, A; Kaczmarek, HJ; Kopish, AJ; Steinpreis, RE
      The effects of amperozide on cocaine-induced social withdrawal in rats

      BEHAVIOURAL BRAIN RESEARCH
    55. Sekine, Y; Rikihisa, T; Ogata, H; Echizen, H; Arakawa, Y
      Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    56. Kitayama, H; Kiuchi, K; Nejima, J; Katoh, T; Takano, T; Hayakawa, H
      Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    57. Crook, JM; Dean, B; Pavey, G; Copolov, D
      The binding of [H-3]AF-DX 384 is reduced in the Caudate-Putamen of subjects with schizophrenia

      LIFE SCIENCES
    58. Elliott, J; Reynolds, GP
      Agonist-stimulated GTP gamma[S-35] binding to 5-HT1A receptors in human post-mortem brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Jelovac, N; Sikiric, P; Rucman, R; Petek, M; Marovic, A; Perovic, D; Seiwerth, S; Mise, S; Turkovic, B; Dodig, G; Miklic, P; Buljat, G; Prkacin, I
      Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Poncelet, M; Barnouin, MC; Breliere, JC; Le Fur, G; Soubrie, P
      Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

      PSYCHOPHARMACOLOGY
    61. Taylor, G; Bardgett, M; Csernansky, J; Early, T; Haller, J; Scherrer, J; Womack, S
      Neuroleptic influences on a lateralized behavioral bias in unoperated rats

      PSYCHOPHARMACOLOGY
    62. Ninan, I; Kulkarni, SK
      Differential effects of olanzapine at dopamine D-1 and D-2 receptors in dopamine depleted animals

      PSYCHOPHARMACOLOGY
    63. Tauscher, J; Kufferle, B; Asenbaum, S; Fischer, P; Pezawas, L; Barnas, C; Tauscher-Wisniewski, S; Brucke, T; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

      PSYCHOPHARMACOLOGY
    64. Frieboes, RM; Murck, H; Antonijevic, I; Kraus, T; Hinze-Selch, D; Pollmacher, T; Steiger, A
      Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls

      PSYCHOPHARMACOLOGY
    65. HORI A
      PHARMACOTHERAPY FOR PERSONALITY-DISORDERS

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    66. CHRISTIAN BT; BABICH JW; LIVNI E; ALPERT NM; BONAB AA; MUNCONI L; POLINSKI R; RUBIN RH; FISCHMAN AJ
      POSITRON EMISSION TOMOGRAPHIC ANALYSIS OF CENTRAL DOPAMINE D-1 RECEPTOR-BINDING IN NORMAL SUBJECTS TREATED WITH THE ATYPICAL NEUROLEPTIC, SDZ MAR-327

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    67. BERNA M; SHUGERT R; MULLEN J
      DETERMINATION OF OLANZAPINE IN HUMAN PLASMA AND SERUM BY LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY

      Journal of mass spectrometry
    68. Fink-Jensen, A; Kristensen, P; Shannon, HE; Calligaro, DO; Delapp, NW; Whitesitt, C; Ward, JS; Thomsen, C; Rasmusseen, T; Sheardown, MJ; Jeppesen, L; Sauerberg, P; Bymaster, FP
      Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats

      NEUROREPORT
    69. MCCOY L; COX C; RICHFIELD EK
      ANTIPSYCHOTIC DRUG REGULATION OF AMPA RECEPTOR AFFINITY STATES AND GLUR1, GLUR2 SPLICE VARIANT EXPRESSION

      Synapse
    70. OLAUSSON P; ERICSON M; PETERSSON A; KOSOWSKI A; SODERPALM B; ENGEL JA
      NEFAZODONE ATTENUATES THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF ETHANOL

      Alcohol
    71. WEST MW; KALMUS G; MYERS RD
      LIMITED ACCESS TO ETHANOL IN GENETIC DRINKING RATS IS SUPPRESSED WHILE FEEDING IS ENHANCED BY THE MIXED 5-HT1A AGONIST 5-HT2A ANTAGONIST FG5938

      Pharmacology, biochemistry and behavior
    72. VANECEK SA; ESSMAN WD; TAYLOR DP; WOODS JH
      DISCRIMINATIVE STIMULUS CHARACTERISTICS OF BMY-14802 IN THE PIGEON

      The Journal of pharmacology and experimental therapeutics
    73. SAGARA Y
      INDUCTION OF REACTIVE OXYGEN SPECIES IN NEURONS BY HALOPERIDOL

      Journal of neurochemistry
    74. ICHIKAWA J; KUROKI T; DAI J; MELTZER HY
      EFFECT OF ANTIPSYCHOTIC-DRUGS ON EXTRACELLULAR SEROTONIN LEVELS IN RAT MEDIAL PREFRONTAL CORTEX AND NUCLEUS-ACCUMBENS

      European journal of pharmacology
    75. WANG RY; ARVANOV VL
      M100907, A HIGHLY SELECTIVE 5-HT2A RECEPTOR ANTAGONIST AND A POTENTIAL ATYPICAL ANTIPSYCHOTIC DRUG, FACILITATES INDUCTION OF LONG-TERM POTENTIATION IN AREA CA1 OF THE RAT HIPPOCAMPAL SLICE

      Brain research
    76. LIU YJ; STAGNI G; WALDEN JG; SHEPHERD AMM; LICHTENSTEIN MJ
      THIORIDAZINE DOSE-RELATED EFFECTS ON BIOMECHANICAL FORCE PLATFORM MEASURES OF SWAY IN YOUNG AND OLD MEN

      Journal of the American Geriatrics Society
    77. LASSER RA; SUNDERLAND T
      NEWER PSYCHOTROPIC MEDICATION USE IN NURSING-HOME RESIDENTS

      Journal of the American Geriatrics Society
    78. SCHMIDT I; CLAESSON CB; WESTERHOLM B; NILSSON LG; SVARSTAD BL
      THE IMPACT OF REGULAR MULTIDISCIPLINARY TEAM INTERVENTIONS ON PSYCHOTROPIC PRESCRIBING IN SWEDISH NURSING-HOMES

      Journal of the American Geriatrics Society
    79. CHRISTENSEN DB; BENFIELD WR
      ALPRAZOLAM AS AN ALTERNATIVE TO LOW-DOSE HALOPERIDOL IN OLDER, COGNITIVELY IMPAIRED NURSING FACILITY PATIENTS

      Journal of the American Geriatrics Society
    80. FOWLER SC; LION JR
      HALOPERIDOL, RACLOPRIDE, AND ETICLOPRIDE INDUCE MICROCATALEPSY DURINGOPERANT PERFORMANCE IN RATS, BUT CLOZAPINE AND SCH-23390 DO NOT

      Psychopharmacology
    81. KASPER S; TAUSCHER J; KUFFERLE B; BARNAS C; HESSELMANN B; ASENBAUM S; PODREKA I; BRUCKE T
      SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY

      Psychopharmacology
    82. GEFVERT O; BERGSTROM M; LANGSTROM B; LUNDBERG T; LINDSTROM L; YATES R
      TIME-COURSE OF CENTRAL NERVOUS DOPAMINE-D-2 AND 5-HT2 RECEPTOR BLOCKADE AND PLASMA DRUG CONCENTRATIONS AFTER DISCONTINUATION OF QUETIAPINE (SEROQUEL(R)) IN PATIENTS WITH SCHIZOPHRENIA

      Psychopharmacology
    83. YUDOFSKY SC; KOPECKY HJ; KUNIK M; SILVER JM; ENDICOTT J
      THE OVERT AGITATION SEVERITY SCALE FOR THE OBJECTIVE RATING OF AGITATION

      The Journal of neuropsychiatry and clinical neurosciences
    84. THACKER S; JONES R
      NEUROLEPTIC PRESCRIBING TO THE COMMUNITY ELDERLY IN NOTTINGHAM

      International journal of geriatric psychiatry
    85. PEHEK EA; BI YM
      RITANSERIN ADMINISTRATION POTENTIATES AMPHETAMINE-STIMULATED DOPAMINERELEASE IN THE RAT PREFRONTAL CORTEX

      Progress in neuro-psychopharmacology & biological psychiatry
    86. ADAMS MR; DOBIE DJ; MERCHANT KM; UNIS A; DORSA DM
      EEDQ REDUCES THE STRIATAL NEUROTENSIN MESSENGER-RNA RESPONSE TO HALOPERIDOL

      Peptides
    87. BUCKLAND PR; DSOUZA U; MAHER NA; MCGUFFIN P
      THE EFFECTS OF ANTIPSYCHOTIC-DRUGS ON THE MESSENGER-RNA LEVELS OF SEROTONIN 5HT(2A) AND 5HT(2C) RECEPTORS

      Molecular brain research
    88. LENERT LA; MORSS S; GOLDSTEIN MK; BERGEN MR; FAUSTMAN WO; GARBER AM
      MEASUREMENT OF THE VALIDITY OF UTILITY ELICITATIONS PERFORMED BY COMPUTERIZED INTERVIEW

      Medical care
    89. HASHIMOTO K; NARITA N; TOMITAKA S; IYO M; MINABE Y
      IN-VIVO REGULATION OF SEROTONIN 5-HT2A RECEPTORS IN RAT-BRAIN BY SUBCHRONIC ADMINISTRATION OF SIGMA-RECEPTOR LIGAND NE-100

      Life sciences
    90. SEEMAN P; KAPUR S
      CLOZAPINE OCCUPIES HIGH-LEVELS OF DOPAMINE D2 RECEPTORS

      Life sciences
    91. PALKOVITS M; BAFFI JS; BERZSENYI P; HORVATH EJ
      ANXIOLYTIC HOMOPHTHALAZINES INCREASE FOS-LIKE IMMUNOREACTIVITY IN SELECTED BRAIN-AREAS OF THE RAT

      European journal of pharmacology
    92. ISHIKANE T; KUSUMI I; MATSUBARA R; MATSUBARA S; KOYAMA T
      EFFECTS OF SEROTONERGIC AGENTS ON THE UP-REGULATION OF DOPAMINE D-2 RECEPTORS INDUCED BY HALOPERIDOL IN RAT STRIATUM

      European journal of pharmacology
    93. INOUE A; MIKI S; SETO M; KIKUCHI T; MORITA S; UEDA H; MISU Y; NAKATA Y
      ARIPIPRAZOLE, A NOVEL ANTIPSYCHOTIC DRUG, INHIBITS QUINPIROLE-EVOKED GTPASE ACTIVITY BUT DOES NOT UP-REGULATE DOPAMINE D-2 RECEPTOR FOLLOWING REPEATED TREATMENT IN THE RAT STRIATUM

      European journal of pharmacology
    94. FRIEBOES RM; MURCK H; WIEDEMANN K; HOLSBOER F; STEIGER A
      OPEN CLINICAL-TRIAL ON THE SIGMA-LIGAND PANAMESINE IN PATIENTS WITH SCHIZOPHRENIA

      Psychopharmacology
    95. SPORE D; MOR V; LARRAT EP; HIRIS J; HAWES C
      REGULATORY ENVIRONMENT AND PSYCHOTROPIC USE IN BOARD-AND-CARE FACILITIES - RESULTS OF A 10-STATE STUDY

      The journals of gerontology. Series A, Biological sciences and medical sciences
    96. LANTZ MS; GIAMBANCO V; BUCHALTER EN
      A 10-YEAR REVIEW OF THE EFFECT OF OBRA-87 ON PSYCHOTROPIC PRESCRIBINGPRACTICES IN AN ACADEMIC NURSING-HOME

      Psychiatric services
    97. VRTUNSKI PB; KONICKI PE; KWON KY; JASKIW GJ; JASKIW GE
      EFFECT OF CLOZAPINE ON MOTOR FUNCTION IN SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    98. MYERS RD; LANKFORD MF
      SUPPRESSION OF ALCOHOL PREFERENCE IN HIGH ALCOHOL-DRINKING RATS - EFFICACY OF AMPEROZIDE VERSUS NALTREXONE

      Neuropsychopharmacology
    99. MCCOY L; RICHFIELD EK
      CHRONIC ANTIPSYCHOTIC TREATMENT ALTERS GLYCINE-STIMULATED NMDA RECEPTOR-BINDING IN RAT-BRAIN

      Neuroscience letters
    100. MODELL S; NABER D; HOLZBACH R
      EFFICACY AND SAFETY OF AN OPIATE SIGMA-RECEPTOR ANTAGONIST (SL-82.0715) IN SCHIZOPHRENIC-PATIENTS WITH NEGATIVE SYMPTOMS - AN OPEN DOSE-RANGE STUDY

      Pharmacopsychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 03:46:54